Drug news: Cationorm - OTC drop from Novagali released in France

According to an April 9 press release, Cationorm has been released in France as an unpreserved over-the-counter drug and is expected to be released as an OTC in the US by the end of 2008. It is described as:

a cationic emulsion with no active principle, for the relief of mild dry eye syndrome

utilizing Novagali's "Novasorb" technology which is "based on the electrostatic attraction that occurs between the droplets of a positively-charged emulsion and the negatively charged cells of the ocular surface, including cornea and conjunctiva."

Last time I heard any news of this one was from ARVO last year where it was reportedly "well tolerated" and showed "upward trending" in clinical signs. My notes to myself at the time included "But did it outperform placebo?" Well, if any of you try it and like it, let me know.